In July, a herd of about 20 cows jumped out of their field and had been on the lam ever since — contentedly grazing wherever they like and wreaking havoc on farmers' fields nearby.

In the first quarter of 2001, Bio-Rad reported $200 million in revenue. About $18 million came from the Mad Cow test. Reach Mladinich at [email protected] or 925-598-1432.

Ontario Provincial Police officers say half a dozen cows found wandering along Highway 400 west of Newmarket are now off the busy road, but the incident created major delays for drivers heading north ...

The lure: a major share of the European testing market for Great Britain's infamous "mad cow disease." Bio-Rad forecasts that market could be worth as much as $200 million.

Competitors such as Switzerland's Roche Holding AG and Abbott Laboratories also sell mad-cow tests, but analysts say Bio-Rad dominates the market, with a 70% share in Europe and 100% in Japan.

Wednesday after the first documented case of mad cow disease in the U.S. bolstered prospects for the company's diagnostic test. Bio-Rad closed up $10.07, or 20.2%, at $59.85. The stock had traded ...

Bio-Rad isn't the only company in the mad-cow diagnostics field. Shares of Orchid BioSciences Inc., a Princeton, N.J., company that is developing advanced tests for the disease, rose 14 cents, or ...

The Baird analyst based this estimate on a scenario in which the USDA decides to test about 700,000 cattle a year for BSE, up from 20,000 now, and assumed 100 percent market share for Bio-Rad.

NEW YORK (CBS.MW) -- Bio-Rad Laboratories BIO, +0.97% said its rapid TeSe test for the detection of mad-cow disease has been approved by the U.S. Department of Agriculture for use in national ...

Bio-Rad Laboratories Inc. of Hercules, California, thought it had a sure thing: It owns the license for one of only three test kits certified in the European Union to detect mad-cow disease.